Sai Life Sciences Limited has informed the Exchange about receipt of an Order dated 30th December, 2025, passed by the Additional Commissioner, Ranga Reddy GST Commissionerate, Hyderabad u/s 74 of the Central Goods and Services Tax Act, 2017
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Smallcap 250 and 1.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sai Life Sciences has received an order dated 30 December 2025 from the Additional Commissioner, Ranga Reddy GST Commissionerate, Hyderabad, under Section 74 of the CGST Act, 2017, raising a penalty demand of ₹4,93,36,015 (approximately ₹4.93 crore). The demand relates to alleged excess availment of Input Tax Credit (ITC) and alleged differences between B2B supplies reported and the Sale/Purchase register on the GST portal for financial years 2018-19 to 2021-22. The company has stated it will file an appeal before the appellate authority and is hopeful of a favourable outcome. Management does not reasonably expect the order to have any material financial impact on the company.
Likely a minor negative for the stock in the near term due to the regulatory action, but the company is contesting the demand and believes the financial impact will not be material. Investors should watch for updates on the appeal outcome.